HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial
- 1 October 1997
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 350 (9083), 983-990
- https://doi.org/10.1016/s0140-6736(97)03380-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic MillimeterNew England Journal of Medicine, 1996
- Zidovudine Alone or in Combination with Didanosine or Zalcitabine in HIV-Infected Patients with the Acquired Immunodeficiency Syndrome or Fewer Than 200 CD4 Cells per Cubic MillimeterNew England Journal of Medicine, 1996
- Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individualsThe Lancet, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Dilution assay statisticsJournal of Clinical Microbiology, 1994
- A microtitre format point mutation assay: Application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudineJournal of Medical Virology, 1992
- HIV-1 sensitivity to zidovudine: A consensus culture technique validated by genotypic analysis of the reverse transcriptaseJournal of Virological Methods, 1992
- Comparative Assessment of Quantitative HIV Viraemia AssaysAIDS, 1992
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- On closed testing procedures with special reference to ordered analysis of varianceBiometrika, 1976